Effect of triglycerides on growth hormone (GH)-releasing factor-mediated GH secretion in newborn calves.
Coxam. V V; Davicco. M J MJ; Barlet. J P JP
Key Findings
- Elevated blood triglycerides blunt the GH response to GRF‑1‑29.
- Lipid‑heparin infusion raises somatostatin (SRIF) levels.
- The inhibitory effect is seen within minutes after GRF injection.
Practical Outcomes
- For people using GHRH peptides, high‑fat meals or spikes in blood triglycerides might lessen the peptide's effectiveness. Timing GHRH dosing away from large lipid loads could help maximize GH release. This insight is modest but useful for optimizing protocols.
Summary
In newborn calves, giving a lipid infusion that raises blood triglycerides reduced the growth hormone boost normally caused by a synthetic GH‑releasing factor (GRF‑1‑29). The drop in GH was linked to higher levels of somatostatin, a hormone that blocks GH release.
Abstract
The effect of triglycerides (Tg) on GRF-mediated GH secretion was examined in 2 groups of twelve ten-day old male calves. Twelve calves were intravenously infused with a lipid-heparin solution (5 mg Tg and 0.3 IU heparin/kg body wt/min for 90 min). The twelve control calves received in the same way, the same volume of saline. Thirty minutes after the start of infusion, GRF 1-29 (human amide, 0.16 micrograms/kg body wt) was intravenously injected in six animals of each group. Mean plasma GH levels reached peak concentrations in the 2 groups 5 min after GRF injection. However the area under the GH response curve, when lipid-heparin was given, was significantly diminished compared to the response when saline was given. In the same time, lipid-heparin treatment increased plasma SRIF concentration. These data suggest that an increase in plasma Tg concentration, induced by lipid-heparin infusion, inhibits GRF-mediated GH secretion, possibly through stimulation of SRIF secretion.
Study Information
pubmed
1989
1989-10-01T00:00:00.000Z
10.1016/0739-7240(89)90033-7
15
18